公司資料

MEI Pharma 股價、新聞與催化劑

股票代碼:: MEIP
交易所:: NASDAQ
產業:: Biopharma
所在地:: United States

股價為何變動

Current closing-price context is not available for MEIP.

公司概覽

業務概覽

MEI Pharma was an oncology company focused on targeted cancer therapies before its restructuring and public-market decline. Its story centered on a concentrated development portfolio.

所在地與產業分類

Headquartered in the United States and listed on NASDAQ before restructuring, MEI sat in specialty oncology biotechnology.

商業模式特徵

The company depended on clinical data, portfolio management, and strategic capital decisions.

生技產業定位

MEI belongs to the historical oncology-biotech category rather than the current live public-company set.

未來催化劑

MEI Pharma’s catalysts are strategic and portfolio-related, with any remaining oncology or capital update doing the work. The company is no longer a clear live-development story.